Verastem Inc VSTM.OQ VSTM.O is expected to show a rise in quarterly revenue when it reports results on March 17 (estimated) for the period ending December 31 2024
The Needham Massachusetts-based company is expected to report revenue of $150 thousand, according to the mean estimate from 8 analysts, based on LSEG data.
LSEG's mean analyst estimate for Verastem Inc is for a loss of 81 cents per share.
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 8 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."
The mean earnings estimate of analysts was unchanged in the last three months.
Wall Street's median 12-month price target for Verastem Inc is $13.00, above its last closing price of $7.21.
Previous quarterly performance (using preferred earnings measure in US dollars).
QUARTER ENDING | STARMINESMARTESTIMATE® | LSEG IBES ESTIMATE | ACTUAL | BEAT, MET, MISSED | SURPRISE % |
Sep. 30 2024 | -0.70 | -0.74 | -0.60 | Beat | 18.7 |
Jun. 30 2024 | -0.93 | -0.95 | -0.31 | Beat | 67.5 |
Mar. 31 2024 | -1.03 | -1.00 | -1.26 | Missed | -26.4 |
Dec. 31 2023 | -0.74 | -0.62 | -1.02 | Missed | -64.5 |
Sep. 30 2023 | -0.87 | -0.84 | -0.75 | Beat | 11 |
Jun. 30 2023 | -1.07 | -1.06 | -1.37 | Missed | -29.2 |
Mar. 31 2023 | -0.96 | -0.98 | -0.96 | Beat | 2.4 |
Dec. 31 2022 | -1.20 | -1.18 | -0.96 | Beat | 18.4 |
This summary was machine generated March 14 at 13:13 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。